WallStreetZen

NASDAQ: AMGN
Amgen Inc Stock Forecast, Predictions & Price Target

Analyst price target for AMGN

Based on 18 analysts offering 12 month price targets for Amgen Inc.
Min Forecast
$185.00-24.64%
Avg Forecast
$259.06+5.53%
Max Forecast
$304.00+23.83%

Should I buy or sell AMGN stock?

Buy
Strong Buy
8 analysts 36.36%
Buy
1 analysts 4.55%
Hold
12 analysts 54.55%
Sell
0 analysts 0%
Strong Sell
1 analysts 4.55%

Forecast return on equity

Is AMGN forecast to generate an efficient return?
Company
105.47%
Industry
74.22%
Market
62.25%
AMGN's Return on Equity is forecast to be high in 4 years (105.47%); analysts are confident in the firm's ability to efficiently generate return on equity
Forecast

Forecast return on assets

Is AMGN forecast to generate an efficient return on assets?
Company
17.88%
Industry
16.87%
Market
19.66%
AMGN is forecast to generate higher Return on Assets (17.88%) than the US Drug Manufacturers - General industry average (16.87%)
Forecast

AMGN earnings per share forecast

What is AMGN's earnings per share in the next 3 years based on estimates from 14 analysts?
Avg 1 year Forecast
$17.00+36.07%
Avg 2 year Forecast
$18.53+48.33%
Avg 3 year Forecast
$18.92+51.46%
AMGN's earnings are forecast to grow at a rate of 15.38% per year, which is not exceptional
Forecast

AMGN revenue forecast

What is AMGN's revenue in the next 3 years based on estimates from 10 analysts?
Avg 1 year Forecast
$26.2B+4.85%
Avg 2 year Forecast
$27.0B+8.06%
Avg 3 year Forecast
$27.7B+11.02%
AMGN's revenue is forecast to grow at a rate of 3.56% per year, which is not exceptional
Forecast

AMGN earnings growth forecast

How is AMGN forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
15.38%
Industry
24.82%
Market
20.47%
AMGN's earnings are forecast to grow slower (15.38% per year) than the US Drug Manufacturers - General industry average (24.82%)
Forecast
AMGN's earnings are forecast to grow slower (15.38% per year) than the US market average (20.47%)
Forecast
AMGN's earnings are forecast to grow faster (15.38% per year) than the risk-free savings rate (1.1%)
Forecast

AMGN revenue growth forecast

How is AMGN forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
3.56%
Industry
6.43%
Market
14.48%
AMGN's revenues are forecast to grow slower (3.56% per year) than the US Drug Manufacturers - General industry average (6.43%)
Forecast
AMGN's revenues are forecast to grow slower (3.56% per year) than the US market average (14.48%)
Forecast

Amgen Stock Forecast FAQ

Is Amgen Stock a good buy in 2020, according to Wall Street analysts?

The consensus among 22 Wall Street analysts covering (NASDAQ: AMGN) stock is to Buy AMGN stock.

Out of 22 analysts, 8 (36.36%) are recommending AMGN as a Strong Buy, 1 (4.55%) are recommending AMGN as a Buy, 12 (54.55%) are recommending AMGN as a Hold, 0 (0%) are recommending AMGN as a Sell, and 1 (4.55%) are recommending AMGN as a Strong Sell.

What is AMGN's Price Target?

According to 18 Wall Street analysts that have issued a 1 year AMGN price target, the average AMGN price target is $259.06, with the highest AMGN stock price forecast at $304.00 and the lowest AMGN stock price forecast at $185.00.

On average, Wall Street analysts predict that Amgen's share price could reach $259.06 by Jan 13, 2022. The average Amgen stock price prediction forecasts a potential upside of 5.53% from the current AMGN share price of $245.49.

What is AMGN's earnings growth forecast for 2021-2023?

(NASDAQ: AMGN) Amgen's forecast annual earnings growth rate of 15.38% is not forecast to beat the US Drug Manufacturers - General industry's average forecast earnings growth rate of 24.82%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 20.47%.

Amgen's earnings in 2020 is $7,352,000,000.On average, 14 Wall Street analysts forecast AMGN's earnings for 2021 to be $9,953,865,706, with the lowest AMGN earnings forecast at $9,353,529,587, and the highest AMGN earnings forecast at $10,583,486,514. On average, 10 Wall Street analysts forecast AMGN's earnings for 2022 to be $10,850,562,876, with the lowest AMGN earnings forecast at $9,786,942,980, and the highest AMGN earnings forecast at $12,141,431,956.

In 2023, AMGN is forecast to generate $11,079,627,711 in earnings, with the lowest earnings forecast at $10,202,785,561 and the highest earnings forecast at $11,854,442,006.

What is AMGN's revenue growth forecast for 2021-2023?

(NASDAQ: AMGN) Amgen's forecast annual revenue growth rate of 3.56% is not forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 6.43%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.48%.

Amgen's revenue in 2020 is $24,987,000,000.On average, 10 Wall Street analysts forecast AMGN's revenue for 2021 to be $15,345,107,207,441, with the lowest AMGN revenue forecast at $14,834,451,933,200, and the highest AMGN revenue forecast at $15,864,101,589,650. On average, 9 Wall Street analysts forecast AMGN's revenue for 2022 to be $15,813,695,611,986, with the lowest AMGN revenue forecast at $15,312,378,053,600, and the highest AMGN revenue forecast at $16,259,444,887,775.

In 2023, AMGN is forecast to generate $16,247,228,487,016 in revenue, with the lowest revenue forecast at $15,286,607,527,500 and the highest revenue forecast at $16,793,011,916,800.

What is AMGN's Earnings Per Share (EPS) forecast for 2021-2023?

(NASDAQ: AMGN) Amgen's current Earnings Per Share (EPS) is $12.49. On average, analysts forecast that AMGN's EPS will be $17.00 for 2021, with the lowest EPS forecast at $15.97, and the highest EPS forecast at $18.07. On average, analysts forecast that AMGN's EPS will be $18.53 for 2022, with the lowest EPS forecast at $16.71, and the highest EPS forecast at $20.73. In 2023, AMGN's EPS is forecast to hit $18.92 (min: $17.42, max: $20.24).

What is AMGN's forecast return on equity (ROE) for 2021-2024?

(NASDAQ: AMGN) forecast ROE is 105.47%, which is considered strong.

What is AMGN's forecast return on assets (ROA) for 2021-2024?

(NASDAQ: AMGN) forecast ROA is 17.88%, which is higher than the forecast US Drug Manufacturers - General industry average of 16.87%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Heap | Mobile and Web Analytics